PL4351590T3 - Koniugat metotreksatu i glukozy do zastosowania w zapobieganiu lub leczeniu chorób autoimmunologicznych - Google Patents

Koniugat metotreksatu i glukozy do zastosowania w zapobieganiu lub leczeniu chorób autoimmunologicznych

Info

Publication number
PL4351590T3
PL4351590T3 PL22820644.7T PL22820644T PL4351590T3 PL 4351590 T3 PL4351590 T3 PL 4351590T3 PL 22820644 T PL22820644 T PL 22820644T PL 4351590 T3 PL4351590 T3 PL 4351590T3
Authority
PL
Poland
Prior art keywords
glucose
preventing
autoimmune diseases
treating autoimmune
methotrexate conjugate
Prior art date
Application number
PL22820644.7T
Other languages
English (en)
Inventor
Siddarth AGRAWAL
Marta WOŹNIAK
Sebastian MAKUCH
Wiesław Szeja
Gabriela PASTUCH-GAWOŁEK
Monika Krawczyk
Jerzy Wiśniewski
Andrzej Gamian
Piotr ZIÓŁKOWSKI
Grzegorz Mazur
Original Assignee
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu filed Critical Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Publication of PL4351590T3 publication Critical patent/PL4351590T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL22820644.7T 2021-06-11 2022-06-13 Koniugat metotreksatu i glukozy do zastosowania w zapobieganiu lub leczeniu chorób autoimmunologicznych PL4351590T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL438135A PL243573B1 (pl) 2021-06-11 2021-06-11 Koniugat metotreksatu i glukozy do zastosowania w zapobieganiu lub leczeniu chorób autoimmunologicznych
PCT/PL2022/050037 WO2022260546A1 (en) 2021-06-11 2022-06-13 A glucose-methotrexate conjugate for use in preventing or treating autoimmune diseases

Publications (1)

Publication Number Publication Date
PL4351590T3 true PL4351590T3 (pl) 2026-04-27

Family

ID=84425365

Family Applications (2)

Application Number Title Priority Date Filing Date
PL438135A PL243573B1 (pl) 2021-06-11 2021-06-11 Koniugat metotreksatu i glukozy do zastosowania w zapobieganiu lub leczeniu chorób autoimmunologicznych
PL22820644.7T PL4351590T3 (pl) 2021-06-11 2022-06-13 Koniugat metotreksatu i glukozy do zastosowania w zapobieganiu lub leczeniu chorób autoimmunologicznych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL438135A PL243573B1 (pl) 2021-06-11 2021-06-11 Koniugat metotreksatu i glukozy do zastosowania w zapobieganiu lub leczeniu chorób autoimmunologicznych

Country Status (3)

Country Link
EP (1) EP4351590B1 (pl)
PL (2) PL243573B1 (pl)
WO (1) WO2022260546A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL243572B1 (pl) * 2021-06-11 2023-09-11 Univ Medyczny Im Piastow Slaskich We Wroclawiu Glikokoniugatowa pochodna metotreksatu i glukozy oraz sposób jej otrzymywania i jej zastosowanie w leczeniu i zapobieganiu nowotworom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200536861A (en) * 2004-04-02 2005-11-16 Denki Kagaku Kogyo Kk Hyaluronic acid/methotrexate compound
PL242529B1 (pl) * 2018-08-20 2023-03-06 Univ Medyczny Im Piastow Slaskich We Wroclawiu Glikokoniugatowa pochodna metotreksatu i glukozy, jej zastosowanie oraz sposób otrzymywania

Also Published As

Publication number Publication date
EP4351590C0 (en) 2025-12-10
EP4351590B1 (en) 2025-12-10
EP4351590A4 (en) 2025-02-26
EP4351590A1 (en) 2024-04-17
PL243573B1 (pl) 2023-09-11
WO2022260546A1 (en) 2022-12-15
PL438135A1 (pl) 2022-12-12

Similar Documents

Publication Publication Date Title
GB2590793B (en) Cannabidiol-C1 for use as a medicament and in the treatment of epilepsy
SMT202400271T1 (it) Composizione farmaceutica per l’uso nel trattamento o nella prevenzione di una patologia correlata a c5
PL4076461T3 (pl) Lumateperon do stosowania w leczeniu schizofrenii
SG10201911828YA (en) A medical waste treatment device
GB201805179D0 (en) Tissue graft for use in surgery
IL304737A (en) Dangapetide for the treatment or prevention of kidney disease
EP4351590A4 (en) GLUCOSE-METHOTREXATE CONJUGATE FOR USE IN THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES
IL306046A (en) A preparation for use in the treatment of disorders related to MHC-1
SG11202008914WA (en) A platform and system for use in therapeutic procedures
PT4313058T (pt) Composição que compreende roginolisib e regime de dosagem para tratar cancro ou uma doença inflamatória ou autoimune
SI4072532T1 (sl) Dozirna oblika za uporabo v zdravljenju ali preprečevanju bolezni
PL4007833T3 (pl) Część sanitarna do wbudowywania i typoszereg części sanitarnych do wbudowywania
SG11202110619XA (en) Mirikizumab for use in a method of treating crohn's disease
GB201912020D0 (en) Therapeutic Conjugate
IL286029A (en) Potassium binding agents for use in hemodialysis patients
GB202104431D0 (en) A mycobacterium for use in cancer therapy
GB202109583D0 (en) Therapeutic agents
GB202010606D0 (en) Therapeutic agents
IL318551A (en) Combination for use in ophthalmology
GB2593556B (en) System for turning a patient over in a bed
GB202312427D0 (en) Treatment for autoimmune disease
GB2625845B (en) Ophiopogonin D for use in the treatment caused by rotavirus infection
GB202003644D0 (en) Treatment for autoimmune diseases
HK40075509A (en) Dosage form for use in treating or preventing of a disease
GB202017752D0 (en) A mycobacterium for use in cancer therapy